Medicus Pharma Ltd. Provides Corporate Updates and Reports Third Quarter 2025 Financial Highlights

Clinical development programs for doxorubicin-containing microneedle array (D-MNA) and Teverelix, a next generation GnRH antagonist, are steadily advancing PHILADELPHIA, PENNSYLVANIA / ACCESS Newswire ...

Iterum Therapeutics (ITRM) Earnings Transcript

Corey and Christine will provide an update on the commercial launch of Orlynda in the U.S. Corey will also give an update on ...